Gene Symbol | JMJD7-PLA2G4B |
---|---|
Entrez Gene | 8681 |
Alt Symbol | HsT16992, cPLA2-beta |
Species | Human |
Gene Type | protein-coding |
Description | JMJD7-PLA2G4B readthrough |
Other Description | JMJD7-PLA2G4B protein|jumonji domain containing 7-phospholipase A2, group IVB (cytosolic) read-through |
Swissprots | P0C869 B4DRT9 Q19KD5 Q19KD6 |
Accessions | EAW92521 AA064721 AB209150 BAD92387 AF065215 AAC78836 AF065216 AF121908 AAD32135 BC013415 BC128426 BC172355 AAI72355 BI768993 BU688449 DA080158 DA096882 DA121536 DQ523799 ABF69195 DQ523800 ABF69196 NM_001198588 NP_001185517 NM_005090 NP_005081 NR_015346 |
Function | Calcium-dependent phospholipase A2 that selectively hydrolyzes glycerophospholipids in the sn-2 position with a preference for arachidonoyl phospholipids. Has a much weaker activity than PLA2G4A. Isoform 3 has calcium-dependent activity against palmitoyl-arachidonyl-phosphatidylethanolamine and low level lysophospholipase activity but no activity against phosphatidylcholine. Isoform 5 does have activity against phosphatidylcholine. {ECO:0000269|PubMed:10085124, ECO:0000269|PubMed:10358058, ECO:0000269|PubMed:16617059}. |
Subcellular Location | Cytoplasm, cytosol {ECO:0000269|PubMed:16617059}. |
Tissue Specificity | Widely expressed. Expressed at higher level in brain, heart, liver, cerebellum and pancreas. Isoform 3 is widely expressed. {ECO:0000269|PubMed:10085124, ECO:0000269|PubMed:10358058, ECO:0000269|PubMed:16617059}. |
Top Pathways | Long-term depression, Choline metabolism in cancer, Oxytocin signaling pathway, VEGF signaling pathway, Inflammatory mediator regulation of TRP channels |
JMJD7-PLA2G4B CRISPR/Cas9 KO Plasmid (h) - sc-418409 from Santa Cruz Biotechnology
|
||||||||
JMJD7-PLA2G4B HDR Plasmid (h) - sc-418409-HDR from Santa Cruz Biotechnology
|
||||||||
JMJD7-PLA2G4B Double Nickase Plasmid (h) - sc-418409-NIC from Santa Cruz Biotechnology
|
||||||||
JMJD7-PLA2G4B Double Nickase Plasmid (h2) - sc-418409-NIC-2 from Santa Cruz Biotechnology
|
||||||||
JMJD7-PLA2G4B CRISPR Activation Plasmid (h) - sc-418409-ACT from Santa Cruz Biotechnology
|
||||||||
JMJD7-PLA2G4B CRISPR Activation Plasmid (h2) - sc-418409-ACT-2 from Santa Cruz Biotechnology
|
||||||||
JMJD7-PLA2G4B Lentiviral Activation Particles (h) - sc-418409-LAC from Santa Cruz Biotechnology
|
||||||||
JMJD7-PLA2G4B Lentiviral Activation Particles (h2) - sc-418409-LAC-2 from Santa Cruz Biotechnology
|
||||||||
group IVB sPLA 2 siRNA (h) - sc-90277 from Santa Cruz Biotechnology
|
||||||||
group IVB sPLA 2 shRNA Plasmid (h) - sc-90277-SH from Santa Cruz Biotechnology
|
||||||||
group IVB sPLA 2 shRNA (h) Lentiviral Particles - sc-90277-V from Santa Cruz Biotechnology
|
||||||||
PLA2G4B RNAi - H00008681-R01 from Novus Biologicals
|
||||||||
MISSION® esiRNA - EHU087201 from Sigma-Aldrich
|
||||||||
CompoZr® Knockout ZFN Kit - CKOZFN10871 from Sigma-Aldrich
|
||||||||
CompoZr® Knockout ZFN Kit, ZFN plasmid only - CKOZFND10871 from Sigma-Aldrich
|
||||||||
MISSION® 3′UTR Lenti GoClone™ - HUTR02476 from Sigma-Aldrich
|
||||||||
shRNA set against Human PLA2G4B(NM_005090.3) - SHR119136 from Creative biogene
|
||||||||
JMJD7-PLA2G4B miRNA 3'UTR clone - MiUTR1H-07961 from Creative biogene
|
||||||||